Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_assertion type Assertion NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_head.
- NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_assertion description "[Additionally, in LDL receptor null mice after influenza infection, D-4F treatment increased plasma HDL levels and paraoxonase activity, and inhibited increased in LDL-cholesterol and peak levels of interleukin-6 post-infection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_provenance.
- NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_assertion evidence source_evidence_literature NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_provenance.
- NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_assertion SIO_000772 14582455 NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_provenance.
- NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_assertion wasDerivedFrom befree-20140225 NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_provenance.
- NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_assertion wasGeneratedBy ECO_0000203 NP524021.RAmQ6A0YyaQuPGnz9EZYtByyDqiBnyr_4qzWKDDUTEPhY130_provenance.